Back

Structural and functional echocardiographic characterisation and prognostic determinants in real-world transthyretin amyloid cardiomyopathy patients on standard of care

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Cardiomyopathies: genetics, biomarkers and diagnostics Cardiomyopathies ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Stefania Marazia

Vito Fazzi Hospital, Lecce (Italy)

5 More presentations in this session

Presentation thumbnail
Lineage-specific conduction heterogeneity and CXCL12/CXCR4 signaling axis activation in human induced pluripotent stem cell models of MYBPC3 deficiency
Doctor V. Jeyakumar (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
Spatial proteomics reveals cell-type-specific drivers in cardiomyopathies
Miss E. Kratz (Munich, DE)
Abstract Slides Video
Presentation thumbnail
From calcium imaging to new functional biomarkers: machine learning unlocks disease-discriminating signatures of cardiac pathologies and arrhythmia syndromes
Doctor T. Kaas (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Growth hormone causes up regulation of Mannose-6-Phosphate receptors and Gb3 mobilization in cultured ERT-treated fabry fibroblasts.
Associate Professor A. Frustaci (Rome, IT)
Abstract Slides Video
Presentation thumbnail
CRISPR/Cas9-mediated GLA gene editing in human iPSC-derived ventricular cardiomyocytes as a model of Fabry cardiomyopathy
Doctor J. Branquinho (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiomyopathies: genetics, biomarkers and diagnostics

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Evolution of echocardiographic parameters during tafamidis therapy in patients with transthyretin cardiac amyloidosis: a real-world cohort study
30 August 2026
thumbnail
Congress Presentation
Right ventricular–pulmonary arterial uncoupling predicts heart failure hospitalisation in transthyretin cardiac amyloidosis
28 August 2026
thumbnail
Congress Presentation
Comparative characteristics of patients with and without transthyretin amyloid cardiomyopathy in the TTRACK study population
17 May 2025
thumbnail
Congress Presentation
The value of left atrio-ventricular coupling index (LACI) in transthyretin amyloidosis: insights from a cohort analysis
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources